BAL 8349

Drug Profile

BAL 8349

Alternative Names: Aerothricin 132; BAL8349; RO 0098349

Latest Information Update: 01 Jul 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Basilea Pharmaceutica; Chugai Pharmaceutical
  • Class Antifungals; Depsipeptides
  • Mechanism of Action Glucan synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Mycoses

Most Recent Events

  • 30 Oct 2002 Nippon Roche has been merged into Chugai Pharmaceutical
  • 29 Apr 2002 Preclinical trials in Mycoses in Japan (unspecified route)
  • 29 Apr 2002 Preclinical trials in Mycoses in Switzerland (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top